Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables RefundsShares Repurchased
Ratios

Cross Country Healthcare (CCRN) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Cross Country Healthcare (CCRN) over the last 15 years, with Q3 2025 value amounting to $4.1 million.

  • Cross Country Healthcare's Accumulated Depreciation & Amortization fell 911.52% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year decrease of 911.52%. This contributed to the annual value of $18.2 million for FY2024, which is 80.12% down from last year.
  • Per Cross Country Healthcare's latest filing, its Accumulated Depreciation & Amortization stood at $4.1 million for Q3 2025, which was down 911.52% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Accumulated Depreciation & Amortization registered a high of $18.3 million during Q4 2023, and its lowest value of $2.2 million during Q2 2021.
  • Over the past 5 years, Cross Country Healthcare's median Accumulated Depreciation & Amortization value was $4.5 million (recorded in 2024), while the average stood at $6.1 million.
  • As far as peak fluctuations go, Cross Country Healthcare's Accumulated Depreciation & Amortization crashed by 4403.16% in 2021, and later soared by 8036.04% in 2023.
  • Cross Country Healthcare's Accumulated Depreciation & Amortization (Quarter) stood at $9.9 million in 2021, then rose by 27.65% to $12.6 million in 2022, then skyrocketed by 45.89% to $18.3 million in 2023, then dropped by 0.8% to $18.2 million in 2024, then crashed by 77.54% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $4.1 million for Q2 2025, and $4.8 million during Q1 2025.